人工耳蜗植入后的疫苗接种建议及脑膜炎风险
Vaccination recommendations and risk of meningitis following cochlear implantation.
作者信息
Kahue Charissa N, Sweeney Alex D, Carlson Matthew L, Haynes David S
机构信息
The Otology Group of Vanderbilt, Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
出版信息
Curr Opin Otolaryngol Head Neck Surg. 2014 Oct;22(5):359-66. doi: 10.1097/MOO.0000000000000092.
PURPOSE OF REVIEW
The Centers for Disease Control and Prevention has established vaccination guidelines for cochlear implant recipients to address the concern for implant-associated bacterial meningitis. Since their inception in 2002, these guidelines have undergone several revisions. We review the rationale and development of the current vaccination schedule.
RECENT FINDINGS
Bacterial meningitis is a rare yet potentially life-threatening complication of cochlear implantation. The recommendations for pneumococcal vaccination have evolved to a state in which nearly all cochlear implant patients receive a combination of both the PCV7 or PCV13 and PPSV23.
SUMMARY
Streptococcus pneumoniae vaccinations have dramatically decreased the incidence of serotype-specific invasive pneumococcal disease across all age groups. However, the optimal timing of immunization remains unclear in cochlear implant candidates.
综述目的
美国疾病控制与预防中心已制定了针对人工耳蜗植入受者的疫苗接种指南，以应对与植入相关的细菌性脑膜炎问题。自2002年这些指南发布以来，已历经多次修订。我们回顾当前疫苗接种时间表的基本原理和制定过程。
最新发现
细菌性脑膜炎是人工耳蜗植入罕见但可能危及生命的并发症。肺炎球菌疫苗接种的建议已发展到几乎所有人工耳蜗植入患者都同时接种PCV7或PCV13以及PPSV23的阶段。
总结
肺炎链球菌疫苗接种已显著降低了所有年龄组中血清型特异性侵袭性肺炎球菌疾病的发病率。然而，人工耳蜗植入候选者的最佳免疫接种时机仍不明确。
Zotero 插件